Higher levels of ZEB1 are associated with aggressive cancer features, high tumor grade, resistance to therapy, metabolic plasticity, increased incidence of metastasis, and worse clinical prognosis in the vast majority of human cancers [10,11,12]. This evidence concerns the gene ZEB1 and neoplasm.